共 50 条
[42]
Combined hypofractionated radiation and hormone therapy for the treatment of intermediate-risk prostate cancer
[J].
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS,
2008, 71 (01)
:58-63
[43]
Hypofractionated stereotactic body radiation therapy as monotherapy for intermediate-risk prostate cancer
[J].
Radiation Oncology,
8
[45]
Dose-Escalated Stereotactic Body Radiation Therapy for Patients With Intermediate- and High-Risk Prostate Cancer: Initial Dosimetry Analysis and Patient Outcomes
[J].
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS,
2016, 95 (03)
:960-964
[49]
Influence of Timing Between Androgen Deprivation Therapy and External Beam Radiation Therapy in Patients with Localized, High-Risk Prostate Cancer
[J].
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS,
2020, 108 (03)
:E877-E877
[50]
Long-term outcomes of hypofractionated radiation therapy in patients with high risk prostate cancer
[J].
ONKOUROLOGIYA,
2024, 20 (01)
:60-66